Device for actively removing a target cell from blood or lymph of a vertebrate subject
2 Assignments
0 Petitions
Accused Products
Abstract
Devices, systems, and methods are described herein for controlling the level of one or more target cell types in the blood fluid and/or lymph fluid of a vertebrate subject. Devices and systems are provided that include a body defining at least one lumen configured for fluid flow; at least one controllable flow barrier to the at least one lumen; one or more sensor configured to detect one or more target cell types in blood fluid or lymph fluid of a vertebrate subject; at least one treatment region disposed within the at least one lumen; at least one reactive component disposed in the at least one treatment region, the at least one reactive component configured to modulate a physiological effect of the one or more target cell types in the vertebrate subject; and at least one controller in communication with the one or more sensor and in communication with the at least one controllable flow barrier to the at least one lumen; wherein the at least one controller is configured to open or close the at least one controllable flow barrier in response to the one or more sensor.
-
Citations
364 Claims
-
1-275. -275. (canceled)
-
276. A method for treating a neoplastic disease or a neoplastic condition in a vertebrate subject comprising:
providing an implantable device comprising;
a body defining at least one lumen configured for fluid flow;
at least one controllable flow barrier to the at least one lumen;
one or more sensor configured to detect one or more target cell types in blood fluid or lymph fluid of a vertebrate subject;
at least one treatment region disposed within the at least one lumen;
at least one reactive component disposed in the at least one treatment region, the at least one reactive component configured to modulate the physiological effect of the one or more target cell types in the vertebrate subject; and
at least one controller in communication with the one or more sensor and in communication with the at least one controllable flow barrier to the at least one lumen;
wherein the at least one controller is configured to open or close the at least one controllable flow barrier in response to the one or more sensor.- View Dependent Claims (277, 278, 279, 280, 281, 282, 283, 284, 285, 286, 287, 288, 289, 290, 291, 292, 293, 294, 295, 296, 297, 298, 299, 300, 302, 303, 304, 307, 308, 309, 310, 311, 312, 313, 314, 315, 316, 320, 321, 327, 328, 331, 335, 336, 344, 345, 346, 347, 349, 356, 358, 361, 362)
-
301. (canceled)
-
305-306. -306. (canceled)
-
317-319. -319. (canceled)
-
322-326. -326. (canceled)
-
329-330. -330. (canceled)
-
332-334. -334. (canceled)
-
337-343. -343. (canceled)
-
348. (canceled)
-
350-355. -355. (canceled)
-
357. (canceled)
-
359-360. -360. (canceled)
-
363. A method for modulating a neoplastic disease or a neoplastic condition in a vertebrate subject comprising:
providing an implantable device comprising;
a body defining at least one lumen configured for fluid flow;
at least one controllable flow barrier to the at least one lumen;
one or more sensor configured to detect one or more target cell types in blood fluid or lymph fluid of a vertebrate subject;
at least one treatment region disposed within the at least one lumen;
at least one reactive component disposed in the at least one treatment region, the at least one reactive component configured to modulate the physiological effect of the one or more target cell types in the vertebrate subject; and
at least one controller in communication with the one or more sensor and in communication with the at least one controllable flow barrier to the at least one lumen;
wherein the at least one controller is configured to open or close the at least one controllable flow barrier in response to the one or more sensor.
-
364-378. -378. (canceled)
Specification